We first performed the ROC curve analysis of CD200, FMC7, and CD79b (markers in CLLflow score apart from CD5 or CD23) expression for CLL diagnosis in the exploratory cohort. The gene discussed is CD79B; the disease is B-cell chronic lymphocytic leukemia.